Researchers at Washington University School of Medicine are recruiting COVID-19 patients for a clinical trial that will examine whether an existing anti-depressant can be an effective treatment for COVID-19.
Eric Lenze, MD, and Caline Mattar, MD, have launched a study into whether a long-used antidepressant can reduce the likelihood that COVID-19 will turn deadly.
With a growing demand for mental health services at colleges, a research team led by Denise E. Wilfley, PhD, has received a $3.8 million grant to test a mental health phone app to treat depression, anxiety and eating disorders in a study involving some 8,000 students at 20 colleges, universities and community colleges.
“We believe that this is one of the first, if not the first, studies of functional brain connectivity in relationship to restricted and repetitive behaviors in the first years of life,” says lead investigator John Pruett, associate professor of psychiatry.
Assistant professor and child psychiatrist Natasha Marrus, MD, PhD, shares her experience specializing in autism.
Theodore J. Cicero, PhD, is the 2018 recipient of the Pioneer Award from the National Council on Alcoholism and Drug Abuse (NCADA).
Researchers at Washington University School of Medicine in St. Louis are launching a large-scale study involving people who have used opioids recreationally but not become dependent on the drugs.
Study led by Dr. Charles Conway focuses on people not treated effectively with antidepressants.
Study also shows drop in marijuana-related arrests
